Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps

  1. Varela-Rey, Iria 234
  2. de la Iglesia, Daniel 1
  3. San Bruno-Ruz, Alba 1
  4. Mejuto-Fernández, Rafael 1
  5. Monteserín-Ron, Luzdivina 1
  6. López-Diaz, Javier 1
  7. García-Salom, Pedro 5
  8. González-Cantalapiedra, Antonio 7
  9. Brea, Jose Manuel 6
  10. Piña-Márquez, Rocío 6
  11. Díaz-Tomé, Victoria 4
  12. González-Barcia, Miguel 23
  13. Zarra-Ferro, Irene 23
  14. Mondelo-García, Cristina 23
  15. Dominguez-Muñoz, J Enrique 1
  16. Otero-Espinar, Francisco J 4
  17. Fernández-Ferreiro, Anxo 23
  1. 1 Digestive Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain
  2. 2 Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain
  3. 3 Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain
  4. 4 Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15782
  5. 5 Pharmacy Department, University Clinical Hospital Dr. Balmis, 03010 Alicante, Spain
  6. 6 Biofarma Group, CIMUS, 15706 Santiago de Compostela, Spain
  7. 7 Rof Codina Veterinary Hospital, Lugo, Spain
Revista:
International Journal of Pharmaceutics

ISSN: 0378-5173

Ano de publicación: 2023

Volume: 635

Páxinas: 122706

Tipo: Artigo

DOI: 10.1016/J.IJPHARM.2023.122706 GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: International Journal of Pharmaceutics

Objetivos de desarrollo sostenible

Resumo

Submucosal injection agents are widely used solutions in gastric polyp resection techniques. Currently, many different solutions are used in clinical practice, but most are not authorised for this use or are not biopharmaceutical characterised. The objective of this multidisciplinary work is to test the efficacy of a novel thermosensitive hydrogel designed specifically for this indication.

Referencias bibliográficas

  • Aderibigbe, (2018), Pharmaceutics, 10, pp. 42, 10.3390/pharmaceutics10020042
  • Ahmed, (2020), Curr. Gastroenterol. Rep, 22, pp. 39, 10.1007/s11894-020-00777-z
  • Arantes, V., Aliaga Ramos, J., Abdul Rani, R., Yoshida, N., 2020. Off-label use of 0.4 % sodium hyaluronate teardrops: a safe and effective solution for submucosal injection in gastric endoscopic submucosal dissection. Endosc Int Open 8, E1741–E1747. 10.1055/a-1265-6598.
  • Askin, (2002), Gastrointest. Endosc., 56, pp. 339, 10.1016/S0016-5107(02)70035-7
  • Auerbach, (2010), Food. Chem. Toxicol, 48, pp. 169, 10.1016/j.fct.2009.09.034
  • Bai, (2022), JPharmSci
  • Bruschi, (2007), JPharmSci, 96, pp. 2074
  • Campaña-Seoane, (2014), Int. J. Pharm., 477, pp. 495, 10.1016/j.ijpharm.2014.10.066
  • Castro, (2019), World. J. Gastroenterol, 25, pp. 777, 10.3748/wjg.v25.i7.777
  • Córdova, H., Cuatrecasas, M., García-Rodríguez, A., Montenegro, A., Melo, J., Rodríguez-de Miguel, C., Martínez-Pallí, G., Garcés-Durán, R., Llach, J., Fernández-Esparrach, G., 2019. Successful outcomes of a new combined solution of hyaluronic acid, chondroitin sulfate and poloxamer 407 for submucosal injection: animal survival study. Endosc Int Open 7, E576–E582. 10.1055/a-0869-7757.
  • Cypher, (2019), Am. J. Clin. Pathol, 152, pp. S73, 10.1093/ajcp/aqz113.088
  • Dumortier, (2006), Pharm. Res, 23, pp. 2709, 10.1007/s11095-006-9104-4
  • Ferlitsch, (2017), Endoscopy, 49, pp. 270, 10.1055/s-0043-102569
  • Ferraz, Á.A.B., Santa-Cruz, F., Belfort, J.V., Sá, V.C.T., Siqueira, L.T., Araújo-Júnior, J.G.C., n.d. The routine use of the methylene blue test in sleeve gastrectomy: why not? Arq Bras Cir Dig 34, e1612. 10.1590/0102-672020210002e1612.
  • Ferreira, (2016), Endosc. Int. Open, 4, pp. E1
  • Food and Drug Administration (FDA), n.d. Orise Gel. FDA Premarket Notification K180068 Boston Scientific [WWW Document]. URL https://fda.report/PMN/K180068 (accessed 6.14.22b).
  • Food and Drug Administration (FDA), n.d. Composition of Eleview® | Eleview [WWW Document]. Eleview Aries. URL https://eleviewus.com (accessed 12.11.21c).
  • Food and Drug Administration (FDA), n.d. Blue Beacon Submucosal Injectable Solution. FDA Premarket Notification K200071 Micro-Tech (Nanjing) Co., Ltd. [WWW Document]. URL https://fda.report/PMN/K200071 (accessed 6.14.22d).
  • Food and Drug Administration (FDA), n.d. Endoclot. FDA Premarket Notification K191254 EndoClot Plus Co., Ltd. [WWW Document]. URL https://fda.report/PMN/K191254 (accessed 6.14.22e).
  • Food and Drug Administration (FDA), n.d. Everlift Submucosal Lifting Agent. FDA Premarket Notification K191923. [WWW Document]. URL https://fda.report/PMN/K191923 (accessed 6.14.22f).
  • Fundarò, S.P., Salti, G., Malgapo, D.M.H., Innocenti, S., 2022. The Rheology and Physicochemical Characteristics of Hyaluronic Acid Fillers: Their Clinical Implications. International Journal of Molecular Sciences 23, 10518. https://doi.org/10.3390/ijms231810518.
  • Giannino, (2020), Polymers. (Basel), 12, 10.3390/polym12020346
  • Gotoda, (2006), J. Gastroenterol, 41, pp. 929, 10.1007/s00535-006-1954-3
  • Graça, (2020), Carbohydr. Polym, 241, 10.1016/j.carbpol.2020.116364
  • Harrer, (2021), Int. J. Pharm., 601, 10.1016/j.ijpharm.2021.120589
  • Hirose, (2018), J. Mech. Behav. Biomed. Mater, 79, pp. 219, 10.1016/j.jmbbm.2018.01.002
  • Hirun, (2022), Polymers, 14, pp. 1836, 10.3390/polym14091836
  • Huang, (2018), Drug. Deliv, 25, pp. 766, 10.1080/10717544.2018.1450910
  • Jeong, (2021), Polymers, 13, pp. 1696, 10.3390/polym13111696
  • Kethu, S.R., Banerjee, S., Desilets, D., Diehl, D.L., Farraye, F.A., Kaul, V., Kwon, R.S., Mamula, P., Pedrosa, M.C., Rodriguez, S.A., Wong Kee Song, L.-M., Tierney, W.M., 2010. Endoscopic tattooing. Gastrointest Endosc 72, 681–685. https://doi.org/10.1016/j.gie.2010.06.020.
  • Ma, (2022), Polymers. (Basel), 14, pp. 1165, 10.3390/polym14061165
  • Mayol, (2011), Biomacromolecules, 12, pp. 28, 10.1021/bm1008958
  • Moles-Aranda, (2020), Pharmaceutics, 12, pp. E322, 10.3390/pharmaceutics12040322
  • Moss, (2010), Gastrointest. Endosc., 71, pp. 589, 10.1016/j.gie.2009.10.033
  • Nascimento, (2018), Int. J. Biol. Macromol, 111, pp. 1245, 10.1016/j.ijbiomac.2018.01.064
  • Neuman, (2015), J. Pharm. Pharm. Sci., 18, pp. 53, 10.18433/J3K89D
  • Pimentel-Nunes Pedro, Libânio Diogo, Barbara, A. J. Bastiaansen, Pradeep Bhandari, Raf Bisschops, Michael J. Bourke, Gianluca Esposito, Arnaud Lemmers, Roberta Maselli, Helmut Messmann, Oliver Pech, Mathieu Pioche, Michael Vieth, Bas L. A. M Weusten, Jeanin E. van Hooft, Pierre H. Deprez, Mario Dinis-Ribeiro, n.d. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022 – European Society of Gastrointestinal Endoscopy (ESGE). URL https://www.esge.com/endoscopic-submucosal-dissection-update-2022/ (accessed 11.23.22).
  • Rashid, (2022), Surg. Oncol., 101742
  • Rohrich, (2007), Plast. Reconstr. Surg., 120, pp. 41S, 10.1097/01.prs.0000248794.63898.0f
  • Ruan, (2022), Molecules, 27, pp. 3063, 10.3390/molecules27103063
  • Sanchez-Ballester, (2021), Carbohydr. Polym., 270, 10.1016/j.carbpol.2021.118399
  • Uemura, (2019), Dig. Endosc, 31, pp. 396, 10.1111/den.13352
  • Varela-Rey, (2020), Revista. de. la. OFIL, 30, pp. 131
  • Wallace, (2017), Gastroenterol. Hepatol. (N. Y), 13, pp. 1
  • Yamamoto, (2008), Gastrointest. Endosc., 67, pp. 830, 10.1016/j.gie.2007.07.039
  • Zarrintaj, (2020), Acta. Biomater., 110, pp. 37, 10.1016/j.actbio.2020.04.028
  • Zhu, (2005), World. J. Gastroenterol, 11, pp. 6090, 10.3748/wjg.v11.i39.6090